EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Revision-Free Survival After MUTARS Total Knee Reconstruction in Limb Salvage Surgery: Primary Implantation Versus Conversion

Fabian Hille, Jan Christoph Theil, Georg Gosheger, Tymoteusz Budny, Marieke de Vaal, Anna Maria Rachbauer, Niklas Deventer iD

Cancers · 29.04.2026 · 18 (9) · 1408

DOI: 10.3390/cancers18091408 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 29.04.2026. Verfasst von Fabian Hille und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics and Tumororthopedics, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149 Muenster, Germany. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Münster.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1)

Background

Megaprosthetic reconstruction of the knee is frequently required in limb salvage surgery for oncologic indications and in complex revision arthroplasty. The Modular Universal Tumor and Revision System (MUTARS) Total Knee prosthesis is widely used in these situations. The aim of this study was to evaluate revision-free implant survival following MUTARS Total Knee implantation and to compare outcomes between primary implantation and use as a conversion procedure after failure of a previous knee prosthesis. (2)

Methods

A retrospective cohort study was performed including 36 patients who underwent MUTARS Total Knee implantation at a single institution. Patients were stratified into primary implantation (n = 24) and conversion after failed prosthesis (n = 12). The primary endpoint was time to first revision. (3)

Results

Overall revision-free survival was 51.6% at 2 years and 29.3% at 5 years. No significant difference in revision-free survival was observed between primary implantation and conversion procedures (log-rank p = 0.67). When mechanical failure (Henderson type III) was considered as the sole endpoint, implant survival was substantially higher, with 88.3% survival at 2 years and 57.2% at 5 years. Infection-related implant survival was 72.0% at both 2 and 5 years. Secondary amputation was required in 7 of 36 patients (19.4%), with a higher proportion observed in the primary implantation group (25.0% vs. 8.3%). Most amputations occurred within the early postoperative period. (4)

Conclusions

MUTARS Total Knee implantation is associated with a substantial revision burden; however, conversion after failed prosthesis did not result in inferior revision-free survival compared with primary implantation. Endpoint-specific analyses demonstrate that biological complications, particularly infection, represent the dominant drivers of early failure.

Schlagwörter

Stichwörter der Autor:innen

MUTARS Total Kneelimb salvage surgerymegaprosthesis

Autor:innen und Institutionen

  • Department of Orthopedics and Tumororthopedics, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149 Muenster, Germany.

ORCID-Profile: Niklas Deventer

Förderung

  • University of Münster

Zitieren

APA

Hille, F., Theil, J. C., Gosheger, G., Budny, T., Vaal, M., Rachbauer, A. M., & Deventer, N. (2026). Revision-Free Survival After MUTARS Total Knee Reconstruction in Limb Salvage Surgery: Primary Implantation Versus Conversion. Cancers, 18(9), 1408. https://doi.org/10.3390/cancers18091408

Vancouver

Hille F, Theil JC, Gosheger G, Budny T, Vaal M, Rachbauer AM, et al. Revision-Free Survival After MUTARS Total Knee Reconstruction in Limb Salvage Surgery: Primary Implantation Versus Conversion. Cancers. 2026;18(9):1408. doi:10.3390/cancers18091408

BibTeX
@article{Hille2026,
  author = {Hille, Fabian and Theil, Jan Christoph and Gosheger, Georg and Budny, Tymoteusz and Vaal, Marieke de and Rachbauer, Anna Maria and Deventer, Niklas},
  title = {Revision-Free Survival After MUTARS Total Knee Reconstruction in Limb Salvage Surgery: Primary Implantation Versus Conversion},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {9},
  pages = {1408},
  doi = {10.3390/cancers18091408}
}
Kostenlos starten →